These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34611001)

  • 1. Impact of empirical oseltamivir discontinuation in hospitalized patients with community-acquired pneumonia after confirmed negative for influenza.
    Alghanem AF; Aldhahri FA; Althemery AU
    Saudi Med J; 2021 Oct; 42(10):1072-1077. PubMed ID: 34611001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia.
    Deshpande A; Klompas M; Yu PC; Imrey PB; Pallotta AM; Higgins T; Haessler S; Zilberberg MD; Lindenauer PK; Rothberg MB
    Chest; 2022 Sep; 162(3):543-555. PubMed ID: 35134384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia.
    Kositpantawong N; Surasombatpattana S; Siripaitoon P; Kanchanasuwan S; Hortiwakul T; Charernmak B; Nwabor OF; Chusri S
    PLoS One; 2021; 16(12):e0261411. PubMed ID: 34910777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder.
    Wilkes JJ; Zaoutis TE; Keren R; Desai B; Leckerman KH; Hodinka RL; Metjian TA; Coffin SE
    J Hosp Med; 2009 Mar; 4(3):171-8. PubMed ID: 19301375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international perspective on hospitalized patients with viral community-acquired pneumonia.
    Radovanovic D; Sotgiu G; Jankovic M; Mahesh PA; Marcos PJ; Abdalla MI; Di Pasquale MF; Gramegna A; Terraneo S; Blasi F; Santus P; Aliberti S; Reyes LF; Restrepo MI;
    Eur J Intern Med; 2019 Feb; 60():54-70. PubMed ID: 30401576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oseltamivir shortens hospital stays of critically ill children hospitalized with seasonal influenza: a retrospective cohort study.
    Coffin SE; Leckerman K; Keren R; Hall M; Localio R; Zaoutis TE
    Pediatr Infect Dis J; 2011 Nov; 30(11):962-6. PubMed ID: 21997661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oseltamivir treatment for influenza in hospitalized children without underlying diseases.
    Bueno M; Calvo C; Méndez-Echevarría A; de José MI; Santos M; Carrasco J; Tovizi M; Guillén S; de Blas A; Llorente M; Tarrago A; Escosa L; Cilleruelo MJ; Tomatis C; Blazquez D; Otheo E; Mazagatos D; García-García ML
    Pediatr Infect Dis J; 2013 Oct; 32(10):1066-9. PubMed ID: 23722530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005.
    Peters PH; Moscona A; Schulman KL; Barr CE
    Medscape J Med; 2008 Jun; 10(6):131. PubMed ID: 18679536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection.
    Groeneveld GH; Marbus SD; Ismail N; de Vries JJC; Schneeberger P; Oosterheert JJ; van Dissel JT; de Boer MGJ
    Int J Antimicrob Agents; 2020 Nov; 56(5):106155. PubMed ID: 32898685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
    Hung IFN; To KKW; Chan JFW; Cheng VCC; Liu KSH; Tam A; Chan TC; Zhang AJ; Li P; Wong TL; Zhang R; Cheung MKS; Leung W; Lau JYN; Fok M; Chen H; Chan KH; Yuen KY
    Chest; 2017 May; 151(5):1069-1080. PubMed ID: 27884765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments.
    Zou Q; Zheng S; Wang X; Liu S; Bao J; Yu F; Wu W; Wang X; Shen B; Zhou T; Zhao Z; Wang Y; Chen R; Wang W; Ma J; Li Y; Wu X; Shen W; Xie F; Vijaykrishna D; Chen Y
    Int J Infect Dis; 2020 Mar; 92():208-213. PubMed ID: 31978583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Oseltamivir in reducing 30-day readmissions and mortality among patients with severe seasonal influenza in Australian hospitalized patients.
    Sharma Y; Horwood C; Hakendorf P; Thompson C
    Int J Infect Dis; 2021 Mar; 104():232-238. PubMed ID: 33434667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes.
    Katzen J; Kohn R; Houk JL; Ison MG
    Clin Infect Dis; 2019 Jun; 69(1):52-58. PubMed ID: 30304487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with severe 2009 H1N1 influenza in the intensive care unit at King Saud Medical City, Saudi Arabia.
    Mady A; Ramadan OS; Yousef A; Mandourah Y; Amr AA; Kherallah M
    J Infect Public Health; 2012 Mar; 5(1):52-6. PubMed ID: 22341843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.
    Hiba V; Chowers M; Levi-Vinograd I; Rubinovitch B; Leibovici L; Paul M
    J Antimicrob Chemother; 2011 May; 66(5):1150-5. PubMed ID: 21393197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in antibiotic and antiviral use in people with confirmed influenza: a retrospective comparison of rapid influenza PCR and multiplex respiratory virus PCR tests.
    Au Yeung V; Thapa K; Rawlinson W; Georgiou A; Post JJ; Overton K
    BMC Infect Dis; 2021 Apr; 21(1):321. PubMed ID: 33827458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oseltamivir and the risk of influenza-related complications and hospitalizations in patients with diabetes.
    Orzeck EA; Shi N; Blumentals WA
    Clin Ther; 2007 Oct; 29(10):2246-55. PubMed ID: 18042482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between influenza treatment and hospitalization-associated outcomes among Korean children with laboratory-confirmed influenza.
    Lim JK; Kim TH; Kilgore PE; Aiello AE; Choi BM; Lee KC; Yoo KH; Song YH; Kim YK
    J Korean Med Sci; 2014 Apr; 29(4):485-93. PubMed ID: 24753694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia.
    Oboho IK; Bramley A; Finelli L; Fry A; Ampofo K; Arnold SR; Self WH; Williams DJ; Courtney DM; Zhu Y; Anderson EJ; Grijalva CG; McCullers JA; Wunderink RG; Pavia AT; Edwards KM; Jain S
    Open Forum Infect Dis; 2017; 4(1):ofw254. PubMed ID: 28480248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
    Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
    BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.